COMMUNIQUÉS West-GlobeNewswire

UPDATE -- Tessera Therapeutics Announces Chief Financial Officer (CFO) Transition and Appointment of Kathy Bergsteinsson as CFO
09/12/2025
SOMERVILLE, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced a planned leadership transition [...]
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
09/12/2025
Board of Directors authorizes new $1 billion share repurchase program WAYNE, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it [...]
Young Americans Lead in HSA Adoption But Carry Heaviest Economic Burden, HealthEquity Research Finds
09/12/2025
New Healthcare Affordability Pulse Reveals Generational Divide in Financial Preparedness and Workplace stress DRAPER, Utah, Dec. 09, 2025 (GLOBE NEWSWIRE) -- As healthcare costs continue to strain American families, [...]
Meiogenix Forms Strategic Advisory Board of Global AgTech Leaders to Accelerate Crop Breeding Transformation
09/12/2025
Research Triangle Park, Durham, North Carolina, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Industry Veterans from Monsanto, Corteva, Cornell, and others guide the advancement of the targeted recombination technology platform [...]
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
09/12/2025
New data will be presented about Precise® Molecular Residual Disease (MRD) Test and MyRisk® Hereditary Cancer Test SALT LAKE CITY, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in [...]
YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN
09/12/2025
Taipei, Taiwan, Dec. 09, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Dandy Acquires Neem to Accelerate Digital Innovation in Dentistry
09/12/2025
Neem’s product, UX, and engineering talent will accelerate Dandy’s transformation of the chair-to-lab experience NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Dandy , the dental technology company, today announced the [...]
Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University
09/12/2025
- First patient in the world treated with Alpha DaRT ® in the brain – - According to the National Brain Tumor Society, glioblastoma is one of the most complex, deadly, and treatment-resistant cancers, with an estimated [...]
Xcell Biosciences and Culture Biosciences Partner to Advance Cell Therapy Quality Through AI and Machine Learning
09/12/2025
Cloud-based platform combines AI and machine learning to perform multivariate analysis, enabling real-time optimization of cell therapy performance and patient outcomes SAN FRANCISCO, CALIFORNIA, UNITED STATES, Dec. 09 [...]
Novo Nordisk has completed its acquisition of Akero Therapeutics
09/12/2025
Bagsværd, Denmark and South San Francisco, CA, US, 9 December 2025 – Novo Nordisk and Akero Therapeutics Inc. (“Akero”) (Nasdaq: AKRO) today announced that Novo Nordisk’s acquisition of Akero, announced on 9 October [...]
Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer
09/12/2025
Data highlights the ability of Akari’s Trop2 ADC, AKTX-101, to kill K-Ras G12V mutated cancer cell lines in preclinical models, potentially addressing one of the most lethal cancers with the lowest survival rates The K- [...]
Clene to Present at the Emerging Growth Conference
09/12/2025
SALT LAKE CITY, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]
Cedar Gate Introduces Next-Generation Solutions for Prospective Bundled Payment Models
09/12/2025
GREENWICH, Conn., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cedar Gate Technologies (Cedar Gate), an IQVIA business and a leader in value-based care technology with over 40 years of experience in bundled payments, has launched [...]
Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing
09/12/2025
VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to announce that the Cannabix Breath Collection [...]
Aprea Therapeutics Announces $3.1 Million Private Placement Priced At-The-Market Under Nasdaq Rules
09/12/2025
Financing from new and existing healthcare focused investors The proceeds are expected to extend the Company’s cash runway into Q1 2027, with potential inflection points anticipated in its clinical programs during that [...]
Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic Shift and Unlock Value, Backed by Additional Investment
09/12/2025
Weinstein brings a global track record of transforming companies through value unlocking, and participation in over 20 M&A transactions and more than $ 5 billion in exits across healthcare, biotechnology, and [...]
A.D.A.M. Innovations Announces the Launch of ALUNAÉ
09/12/2025
The World’s First AI Genomic-Based Skincare Line Designed to Address Japanese and Asian Environmental Skin Aging TOKYO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (Japanese corporate name: Genesis [...]
Cuprina Holdings (Cayman) Limited Announces Financial Results for the Six Months Ended June 30, 2025, and Strategic Initiatives for 2026 Growth
09/12/2025
SINGAPORE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited ( Nasdaq: CUPR ) (“ Cuprina ” or “ the Company ”), a biomedical company developing and marketing products for the chronic wounds, [...]
STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico
09/12/2025
HORSHAM, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a global leader in in-office dermatologic technologies, announces its participation in the 2025 Ibero-Latin American Congress of [...]

Pages